Jazz Pharmaceuticals PLC Sunosi U.S. Investor Update Transcript
(technical difficulty)
This is Kathee Littrell, head of Investor Relations at Jazz. I want to thank you all for joining us for our Sunosi investor update. Before we begin the webcast, I will point out that we will be making forward-looking statements today, including statements regarding our plans and expectations for the Sunosi commercial launch in the U.S., our development plans and opportunities and projected future Sunosi net sales and performance. Our forward-looking statements are subject to risks and uncertainties described in our quarterly report on the Form 10-Q for the quarter ended March 31, 2019, and our other filings with the Securities and Exchange Commission and actual results may differ materially.
We undertake no duty or obligation to update any forward-looking statements we make today. Finally, although, we may comment on 2019 Sunosi net sales expectations in this presentation, we are not confirming or updating any other guidance and actual results may differ.
I'll
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |